ArticleACS biomaterials science & engineering2026
Implantation and Analysis of a Biphasic Bioinspired Osteochondral Chitosan Construct in a Large Animal Model.
Article in ACS biomaterials science & engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteochondral defects are severe degenerative lesions of the joint that involve the articular cartilage, the cartilage-bone interface, and the underlying subchondral bone. Surgical approaches that have been developed (joint debridement, microfracture, autologous chondrocytes and autologous/allograft cartilage implantation, and whole joint replacement) remain, however, more palliative than curative. Therefore, novel strategies are required, including promising options offered by osteochondral tissue engineering approaches. In this study, a novel chitosan-based scaffold with biomimetic and biodegradable properties was implanted for 16 weeks in a sheep osteochondral defect model in order to evaluate its physical stability, biocompatibility, and regenerative potential. Alongside the chitosan construct, a commercial scaffold made of collagen and ß-TCP was implanted as a positive control, while defects left empty were used as negative control. Postoperative recovery and tissue response were evaluated at different levels including activity monitoring, gross tissue evaluation at sacrifice, imaging, and histological analysis. Despite a transient reaction observed in the first 4 weeks after implantation, the chitosan-based scaffold was well-tolerated, with no clear signs of local or systemic reaction in the long term. The chitosan scaffold was able to support the growth of mature bone tissue with a lamellar conformation at similar levels to the predicate control. It also promoted the formation of a new cartilage layer, although not at a fully mature stage. These proof-of-concept results suggest that the novel chitosan scaffold tested constitutes a possible option for osteochondral regeneration, which should be further analyzed in complementary models to provide information on its long-term performance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.